The Role of DNA Methyltransferase Inhibitors in the Modern Therapy of MDS

被引：0
作者：
Savona, Michael R. [1 ,2 ]
机构：
[1] Vanderbilt Ingram Canc Ctr, Nashville, TN 37032 USA
[2] Vanderbilt Univ, Sch Med, Nashville, TN 37032 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
DNMTi; epigenetics; guadecitabine; hypomethylating agents; MDS; myelodysplastic syndromes; oral agents; CHRONIC MYELOMONOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; COMBINATION; DECITABINE;
D O I：
10.1016/j.clml.2019.07.426
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXABS-MDS-
引用
收藏
页码：S77 / S79
页数：3
相关论文
共 19 条
[1]  
[Anonymous], 2017, ANN M AM SOC HEM ATL
[2]  
[Anonymous], 2019, LANCET HAEMATOLOGY
[3]   Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up [J].
Cabrero, Monica ;
Jabbour, Elias ;
Ravandi, Farhad ;
Bohannan, Zach ;
Pierce, Sherry ;
Kantarjian, Hagop M. ;
Garcia-Manero, Guillermo .
LEUKEMIA RESEARCH, 2015, 39 (05) :520-524
[4]   Aberrant CpG-island methylation has non-random and tumour-type-specific patterns [J].
Costello, JF ;
Frühwald, MC ;
Smiraglia, DJ ;
Rush, LJ ;
Robertson, GP ;
Gao, X ;
Wright, FA ;
Feramisco, JD ;
Peltomäki, P ;
Lang, JC ;
Schuller, DE ;
Yu, L ;
Bloomfield, CD ;
Caligiuri, MA ;
Yates, A ;
Nishikawa, R ;
Huang, HJS ;
Petrelli, NJ ;
Zhang, XL ;
O'Dorisio, MS ;
Held, WA ;
Cavenee, WK ;
Plass, C .
NATURE GENETICS, 2000, 24 (02) :132-138
[5]  
DINARDO CD, 2019, J CLIN ONCOL S, V37
[6]   Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia [J].
DiNardo, Courtney D. ;
Pratz, Keith ;
Pullarkat, Vinod ;
Jonas, Brian A. ;
Arellano, Martha ;
Becker, Pamela S. ;
Frankfurt, Olga ;
Konopleva, Marina ;
Wei, Andrew H. ;
Kantarjian, Hagop M. ;
Xu, Tu ;
Hong, Wan-Jen ;
Chyla, Brenda ;
Potluri, Jalaja ;
Pollyea, Daniel A. ;
Letai, Anthony .
BLOOD, 2019, 133 (01) :7-17
[7]   Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia [J].
Garcia-Manero, Guillermo ;
Gore, Steven D. ;
Cogle, Christopher ;
Ward, Renee ;
Shi, Tao ;
MacBeth, Kyle J. ;
Laille, Eric ;
Giordano, Heidi ;
Sakoian, Sarah ;
Jabbour, Elias ;
Kantarjian, Hagop ;
Skikne, Barry .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) :2521-2527
[8]   RETRACTED: 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal (Retracted Article) [J].
Ghoshal, K ;
Datta, J ;
Majumder, S ;
Bai, SM ;
Kutay, H ;
Motiwala, T ;
Jacob, ST .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (11) :4727-4741
[9]   Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study [J].
Kantarjian, H ;
Issa, JPJ ;
Rosenfeld, CS ;
Bennett, JM ;
Albitar, M ;
DiPersio, J ;
Klimek, V ;
Slack, J ;
de Castro, C ;
Ravandi, F ;
Helmer, R ;
Shen, LL ;
Nimer, SD ;
Leavitt, R ;
Raza, A ;
Saba, H .
CANCER, 2006, 106 (08) :1794-1803
[10]   Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia [J].
Konopleva, Marina ;
Pollyea, Daniel A. ;
Potluri, Jalaja ;
Chyla, Brenda ;
Hogdal, Leah ;
Busman, Todd ;
McKeegan, Evelyn ;
Salem, Ahmed Hamed ;
Zhu, Ming ;
Ricker, Justin L. ;
Blum, William ;
DiNardo, Courtney D. ;
Kadia, Tapan ;
Dunbar, Martin ;
Kirby, Rachel ;
Falotico, Nancy ;
Leverson, Joel ;
Humerickhouse, Rod ;
Mabry, Mack ;
Stone, Richard ;
Kantarjian, Hagop ;
Letai, Anthony .
CANCER DISCOVERY, 2016, 6 (10) :1106-1117
12